Mark A. Wright

2.0k total citations
41 papers, 1.7k citations indexed

About

Mark A. Wright is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark A. Wright has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 18 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Mark A. Wright's work include Immunotherapy and Immune Responses (24 papers), Immune Cell Function and Interaction (11 papers) and Cancer Research and Treatments (8 papers). Mark A. Wright is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), Immune Cell Function and Interaction (11 papers) and Cancer Research and Treatments (8 papers). Mark A. Wright collaborates with scholars based in United States, Australia and Japan. Mark A. Wright's co-authors include Matthew R. Young, M. Rita I. Young, Margaret Prechel, Yvonne Lozano, Melvin E. Young, Janet Benefield, G J Petruzzelli, Sonia Collins, John P. Matthews and Michael P. Coogan and has published in prestigious journals such as The Journal of Immunology, International Journal of Cancer and Journal of Leukocyte Biology.

In The Last Decade

Mark A. Wright

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Wright United States 24 1.1k 746 358 142 99 41 1.7k
Raffaella Iannone Italy 19 496 0.5× 389 0.5× 596 1.7× 147 1.0× 41 0.4× 28 1.3k
Tanja Stoyan Germany 13 577 0.5× 615 0.8× 443 1.2× 140 1.0× 43 0.4× 21 1.4k
Ferdinand Rossi United States 25 488 0.5× 638 0.9× 885 2.5× 126 0.9× 97 1.0× 29 2.2k
Laura Bonapace Switzerland 9 428 0.4× 406 0.5× 560 1.6× 148 1.0× 40 0.4× 10 1.2k
Chung Kwon Kim South Korea 20 360 0.3× 523 0.7× 584 1.6× 153 1.1× 43 0.4× 39 1.3k
Tomokazu Aoki Japan 18 288 0.3× 249 0.3× 519 1.4× 134 0.9× 115 1.2× 52 1.2k
Tetsuya Taga Japan 11 437 0.4× 655 0.9× 878 2.5× 256 1.8× 74 0.7× 13 1.7k
Santiago P. Méndez‐Huergo Argentina 15 984 0.9× 245 0.3× 817 2.3× 103 0.7× 114 1.2× 20 1.5k
Brian D. Goetz United States 14 561 0.5× 526 0.7× 413 1.2× 141 1.0× 138 1.4× 24 1.4k
Warren Heston United States 12 181 0.2× 270 0.4× 344 1.0× 97 0.7× 42 0.4× 15 1.1k

Countries citing papers authored by Mark A. Wright

Since Specialization
Citations

This map shows the geographic impact of Mark A. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Wright more than expected).

Fields of papers citing papers by Mark A. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Wright. The network helps show where Mark A. Wright may publish in the future.

Co-authorship network of co-authors of Mark A. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Wright. A scholar is included among the top collaborators of Mark A. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Wright. Mark A. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanabrocki, Eugene L., Ramón C. Hermida, Mark A. Wright, et al.. (2001). CIRCADIAN VARIATION OF SERUM LEPTIN IN HEALTHY AND DIABETIC MEN. Chronobiology International. 18(2). 273–283. 29 indexed citations
2.
Young, M. Rita I., et al.. (1999). Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clinical & Experimental Metastasis. 17(10). 881–888. 34 indexed citations
3.
Young, M. Rita I., Mark A. Wright, Deanne Lathers, & Kelly N. Messingham. (1999). Increased resistance to apoptosis by bone marrow CD34+ progenitor cells from tumor-bearing mice. International Journal of Cancer. 82(4). 609–615. 6 indexed citations
4.
Lathers, Deanne, et al.. (1999). Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different. Human Immunology. 60(12). 1207–1215. 9 indexed citations
6.
Young, Matthew R., Mark A. Wright, Yvonne Lozano, et al.. (1997). Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. International Journal of Cancer. 74(1). 69–74. 133 indexed citations
7.
Wright, Mark A., et al.. (1997). Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. International Journal of Cancer. 73(5). 663–669. 89 indexed citations
8.
Young, Matthew R., Mark A. Wright, Yvonne Lozano, et al.. (1996). Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer. International Journal of Cancer. 67(3). 333–338. 157 indexed citations
11.
Young, Matthew R., et al.. (1996). Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. The Journal of Immunology. 156(5). 1916–1922. 121 indexed citations
12.
Petruzzelli, Guy J., et al.. (1995). Immune parameters of mice bearing human head and neck cancer. Cancer Immunology Immunotherapy. 40(5). 283–291. 13 indexed citations
14.
Young, Matthew R., et al.. (1995). Treating tumor-bearing mice with vitamin D 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunology Immunotherapy. 41(1). 37–45. 11 indexed citations
16.
Young, Matthew R., et al.. (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin.. PubMed. 80(3). 395–400. 82 indexed citations
17.
Young, M. Rita I., et al.. (1992). Stimulation of the metastatic properties of lewis‐lung‐carcinoma cells by autologous granulocyte‐macrophage colony‐stimulating factor. International Journal of Cancer. 50(4). 628–634. 24 indexed citations
18.
Young, Matthew R., et al.. (1992). Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunology Immunotherapy. 35(1). 14–18. 46 indexed citations
19.
Young, Matthew R., et al.. (1992). Regulation of Murine T-Lymphocyte Function by Spleen Cell-Derived and Exogenous Serotonin. Immunopharmacology and Immunotoxicology. 14(4). 783–796. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026